The Muscle Group led by Dr Chris Van Der Poel and Dr Jarrod Church, investigates the mechanisms underlying skeletal muscle disease and the molecular pathways regulating muscle size and function. Research focusses on novel approaches for improving muscle function in diseases such as muscular dystrophy, as well as muscle repair after injury.
Key projects include:
- Role of versican in contractile function of dystrophic muscle
- Therapeutic potential of thymosin beta 4 in muscular dystrophy
- Novel therapeutics to improve skeletal muscle repair